Anthropic launches AI drug discovery program, joining tech giants in betting on healthcare (3 minute read)
Summary
Anthropic is launching an internal AI drug discovery program to develop treatments for neglected diseases, aiming to improve its AI tools for drugmakers and join tech giants in the healthcare market.
View Cached Full Text
Cached at: 07/01/26, 05:19 PM
Similar Articles
Anthropic Veterans' Startup Seeks to Help Scientists Develop Their Own AI (5 minute read)
Mirendil, a startup founded by Anthropic veterans, raised $200 million in seed funding to develop and distribute AI tools that accelerate AI research for everyone.
Anthropic
Anthropic, the AI safety and research company, is in the news.
Ahead of its IPO, Anthropic’s Daniela Amodei shrugs off doubts about AI’s returns
Anthropic is moving toward a public IPO filing after raising $65 billion at a $965 billion valuation, with co-founder Daniela Amodei citing the need for capital to train frontier models and serve inference at scale. The company reported $47 billion in annualized revenue as of May 2026, and has partnered with xAI for $1.25 billion per month in compute capacity rather than building its own data centers.
Anthropic, Microsoft in talks for AI chip deal after $5 billion investment (3 minute read)
Microsoft is in talks to supply its custom Maia 200 AI chips to Anthropic following a $5 billion investment, as Anthropic seeks to address its growing compute needs amid rising popularity of its Claude assistant and Claude Code tool.
Anthropic becomes first AI startup to join the Frontier carbon removal coalition
Anthropic becomes the first AI startup to join the Frontier carbon removal coalition, contributing to a new $915 million funding tranche that brings total pledges to $1.8 billion for carbon removal projects.